Skip to content
Home / Companies / LGND LGN
LIGAND PHARMACEUTICALS INC (LGND) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest LGND Insider Trades
About LIGAND PHARMACEUTICALS INC (LGND) Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
Headquarters SAN DIEGO, CA
Employees 47
Listed 1994
Exchange XNAS https://www.ligand.com SEC filings for LGND on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 36 71,976 $20.08M Grant or award 14 26,418 Option exercise 24 117,848
LGND Insider Transactions (Form 4) 156 57 Form 4 filings on record, the earliest from Dec 2, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 16,179
Recent LGND Form 8-K Filings 5
Recent LGND Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 12, 2026 OCTAVIO ESPINOZA Officer 31,641 $9.14M View on EDGAR Aug 12, 2026 Jason Haas Director
LGND Insider Trading - FAQ
What is the latest insider trade for LGND? LIGAND PHARMACEUTICALS INC (LGND) had 17 insider filings in the last 90 days, with the most recent on 2026-08-14. The full record for LGND runs to 57 Form 4 filings, the earliest from 2024-12-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying LGND stock? No insider purchases of LGND were filed in the last 90 days.
How many insiders are selling LGND stock? 36 insider sales of LGND were filed in the last 90 days, totaling $20.08M.
Where can I see LGND SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks LGND Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow LGND insider buys? Create a free InsiderAlpha account and press Watch on this page to add LGND to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track LGND insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $2.09M
Market cap $5.59B
P/E ratio 29.60
Dividend yield -
Average volume 350.3K
52 week high $326.63
52 week low $158.40
Today's high $284.00
Today's low $277.36
Open $283.70
Volume 127.7K
Previous close $284.52
Shares outstanding 19.94M Market cap
$5.59B
47 employees
LGND Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 36 sales totaling $20.08M.
Most-Active LGND Insiders - Last 90 Days 10 Tax withholding / forfeiture 1 182
Other acquisition / disposition 3 281
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 2,074 $70.04 $145K
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 2,869 $55.75 $160K
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 7,171 $57.22 $410K
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 3,348 $68.74 $230K
Aug 12, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 31,641 $292.07 $9.24M
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Employee Stock Option (right to buy) 2,869 $0.00 -
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Employee Stock Option (right to buy) 7,171 $0.00 -
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Non-Qualified Stock Option (right to buy) 16,179 $0.00 -
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Non-Qualified Stock Option (right to buy) 3,348 $0.00 -
Aug 12, 2026 OE Octavio Espinoza - Officer Option exercise Non-Qualified Stock Option (right to buy) 2,074 $0.00 -
Aug 12, 2026 JH Jason Haas - Director Option exercise Common Stock 6,138 $51.56 $316K
Aug 12, 2026 JH Jason Haas - Director Open-market sale Common Stock 7,138 $292.81 $2.09M
Aug 12, 2026 JH Jason Haas - Director Option exercise Non-Qualified Stock Option (right to buy) 6,138 $0.00 -
Aug 3, 2026 AR Andrew Reardon - Officer Option exercise Common Stock 5,000 $52.27 $261K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 105 $284.14 $30K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 33 $284.55 $9K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 157 $285.74 $45K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,032 $286.80 $296K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,214 $287.77 $349K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 356 $288.75 $103K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 503 $289.80 $146K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 200 $290.60 $58K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 991 $291.71 $289K
Aug 3, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 409 $292.82 $120K
Aug 3, 2026 AR Andrew Reardon - Officer Option exercise Employee Stock Option (right to buy) 5,000 $0.00 -
Jul 1, 2026 AR Andrew Reardon - Officer Option exercise Common Stock 5,000 $52.27 $261K
Jul 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 396 $308.99 $122K
Jul 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 104 $310.20 $32K
Jul 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,119 $311.72 $349K
Jul 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,081 $312.28 $338K
Jul 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 700 $313.46 $219K
Jul 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 100 $314.58 $31K
Jul 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 900 $315.78 $284K
Jul 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 600 $317.15 $190K
Jul 1, 2026 AR Andrew Reardon - Officer Option exercise Employee Stock Option (right to buy) 5,000 $0.00 -
Jun 30, 2026 TD Todd C. Davis - Officer Other Common Stock 132 $160.71 $21K
Jun 16, 2026 SS Stephen L. Sabba - Director Open-market sale Common Stock 2,145 $254.00 $545K
Jun 16, 2026 SS Stephen L. Sabba - Director Option exercise Non-Qualified Stock Option (right to buy) 2,145 $0.00 -
Jun 16, 2026 SS Stephen L. Sabba - Director Option exercise Common Stock 2,145 $66.13 $142K
Jun 12, 2026 JH Jason Haas - Director Option exercise Non-Qualified Stock Option (right to buy) 3,000 $0.00 -
Jun 12, 2026 JH Jason Haas - Director Option exercise Non-Qualified Stock Option (right to buy) 1,000 $0.00 -
Jun 12, 2026 JH Jason Haas - Director Option exercise Common Stock 3,000 $51.56 $155K
Jun 12, 2026 JH Jason Haas - Director Option exercise Common Stock 1,000 $51.56 $52K
Jun 12, 2026 JH Jason Haas - Director Open-market sale Common Stock 3,000 $255.01 $765K
Jun 12, 2026 JH Jason Haas - Director Open-market sale Common Stock 3,461 $256.08 $886K
Jun 10, 2026 JA Jason Aryeh - Director Open-market sale Common Stock 500 $250.00 $125K
Jun 11, 2026 JA Jason Aryeh - Director Open-market sale Common Stock 4,500 $250.00 $1.13M
Jun 5, 2026 JA Jason Aryeh - Director Grant or award Common Stock 836 $0.00 -
Jun 5, 2026 JA Jason Aryeh - Director Grant or award Non-Qualified Stock Option (right to buy) 2,938 $0.00 -
Jun 10, 2026 JL John L. Lamattina - Director Open-market sale Common Stock 3,405 $251.62 $857K
Jun 10, 2026 JL John L. Lamattina - Director Open-market sale Common Stock 697 $249.53 $174K
Jun 5, 2026 MZ Martine Zimmermann - Director Tax withholding / forfeiture Common Stock 182 $237.00 $43K
Jun 5, 2026 MZ Martine Zimmermann - Director Grant or award Non-Qualified Stock Option (right to buy) 2,938 $0.00 -
Jun 5, 2026 SS Stephen L. Sabba - Director Grant or award Non-Qualified Stock Option (right to buy) 2,938 $0.00 -
Jun 5, 2026 JL John L. Lamattina - Director Grant or award Non-Qualified Stock Option (right to buy) 2,938 $0.00 -
Jun 5, 2026 JK John W. Kozarich - Director Grant or award Non-Qualified Stock Option (right to buy) 2,938 $0.00 -
Jun 5, 2026 JH Jason Haas - Director Grant or award Common Stock 836 $0.00 -
Jun 5, 2026 JH Jason Haas - Director Grant or award Non-Qualified Stock Option (right to buy) 2,938 $0.00 -
Jun 5, 2026 NG Nancy Ryan Gray - Director Grant or award Non-Qualified Stock Option (right to buy) 2,938 $0.00 -
Jun 1, 2026 AR Andrew Reardon - Officer Option exercise Common Stock 5,000 $52.27 $261K
Jun 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 491 $223.95 $110K
Jun 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,216 $229.47 $279K
Jun 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 200 $230.41 $46K
Jun 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 677 $225.20 $152K
Jun 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,432 $225.97 $324K
Jun 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 400 $226.78 $91K
Jun 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 584 $228.57 $133K
Jun 1, 2026 AR Andrew Reardon - Officer Option exercise Employee Stock Option (right to buy) 5,000 $0.00 -
May 27, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 764 $63.62 $49K
May 27, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 972 $52.84 $51K
May 27, 2026 OE Octavio Espinoza - Officer Option exercise Employee Stock Option (right to buy) 972 $0.00 -
May 27, 2026 OE Octavio Espinoza - Officer Option exercise Employee Stock Option (right to buy) 764 $0.00 -
May 12, 2026 JK John W. Kozarich - Director Option exercise Common Stock 459 $69.51 $32K
May 12, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 459 $224.00 $103K
May 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 80 $227.37 $18K
May 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 1 $229.87 $230
May 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 165 $231.87 $38K
May 13, 2026 JK John W. Kozarich - Director Option exercise Common Stock 1,575 $69.51 $109K
May 13, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 1,575 $223.50 $352K
May 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 105 $232.57 $24K
May 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 116 $234.09 $27K
May 12, 2026 JK John W. Kozarich - Director Option exercise Non-Qualified Stock Option (right to buy) 459 $0.00 -
May 13, 2026 JK John W. Kozarich - Director Option exercise Non-Qualified Stock Option (right to buy) 1,575 $0.00 -
May 1, 2026 AR Andrew Reardon - Officer Option exercise Common Stock 5,000 $52.27 $261K
May 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 600 $227.45 $136K
May 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 932 $228.75 $213K
May 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 98 $229.71 $23K
May 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 370 $230.87 $85K
May 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 780 $232.04 $181K
May 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,420 $232.92 $331K
May 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 800 $234.02 $187K
May 1, 2026 AR Andrew Reardon - Officer Option exercise Employee Stock Option (right to buy) 5,000 $0.00 -
Apr 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 146 $199.97 $29K
Apr 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 40 $201.24 $8K
Apr 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 79 $202.42 $16K
Apr 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 43 $202.91 $9K
Apr 1, 2026 JK John W. Kozarich - Director Open-market sale Common Stock 159 $204.26 $32K
Apr 1, 2026 AR Andrew Reardon - Officer Option exercise Common Stock 5,000 $52.27 $261K
Apr 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 460 $198.85 $91K
Apr 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,302 $199.72 $260K
Apr 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,238 $200.94 $249K
Apr 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 700 $201.90 $141K
Apr 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 963 $203.22 $196K
Apr 1, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 337 $204.50 $69K
Apr 1, 2026 AR Andrew Reardon - Officer Option exercise Employee Stock Option (right to buy) 5,000 $0.00 -
Mar 6, 2026 JL John L. Lamattina - Director Option exercise Common Stock 2,161 $114.15 $247K
Mar 6, 2026 JL John L. Lamattina - Director Open-market sale Common Stock 2,161 $200.76 $434K
Mar 6, 2026 JL John L. Lamattina - Director Option exercise Non-Qualified Stock Option (right to buy) 2,161 $0.00 -
Mar 2, 2026 OE Octavio Espinoza - Officer Grant or award Employee Stock Option (right to buy) 23,527 $0.00 -
Mar 2, 2026 TD Todd C. Davis - Officer Grant or award Common Stock 10,495 $0.00 -
Mar 2, 2026 TD Todd C. Davis - Officer Grant or award Employee Stock Option (right to buy) 50,058 $0.00 -
Mar 2, 2026 AR Andrew Reardon - Officer Grant or award Common Stock 4,513 $0.00 -
Mar 2, 2026 AR Andrew Reardon - Officer Grant or award Employee Stock Option (right to buy) 21,525 $0.00 -
Mar 23, 2026 SS Stephen L. Sabba - Director Open-market sale Common Stock 1,000 $207.87 $208K
Mar 11, 2026 OE Octavio Espinoza - Officer Option exercise Employee Stock Option (right to buy) 2,405 $0.00 -
Mar 11, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 2,405 $92.65 $223K
Mar 11, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 3,057 $225.00 $688K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,142 $208.87 $239K
Mar 4, 2026 AR Andrew Reardon - Officer Option exercise Employee Stock Option (right to buy) 5,000 $0.00 -
Mar 4, 2026 AR Andrew Reardon - Officer Option exercise Common Stock 5,000 $52.27 $261K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 100 $197.70 $20K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 100 $199.01 $20K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 207 $199.96 $41K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 93 $200.62 $19K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 300 $201.70 $61K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 200 $204.17 $41K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 460 $205.18 $94K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 340 $206.37 $70K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 612 $207.01 $127K
Mar 4, 2026 AR Andrew Reardon - Officer Open-market sale Common Stock 1,446 $208.12 $301K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 698 $201.09 $140K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 950 $201.73 $192K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 697 $202.79 $141K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 668 $203.63 $136K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 743 $204.74 $152K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 1,457 $205.79 $300K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 1,588 $206.89 $329K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 2,457 $207.91 $511K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 3,413 $208.80 $713K
Mar 4, 2026 OE Octavio Espinoza - Officer Option exercise Employee Stock Option (right to buy) 1,607 $0.00 -
Mar 4, 2026 OE Octavio Espinoza - Officer Option exercise Employee Stock Option (right to buy) 466 $0.00 -
Mar 4, 2026 OE Octavio Espinoza - Officer Option exercise Common Stock 1,607 $58.49 $94K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 699 $198.71 $139K
Mar 4, 2026 OE Octavio Espinoza - Officer Open-market sale Common Stock 53 $200.08 $11K
$LNSR
LENSAR, Inc.
$CORT
CORCEPT THERAPEUTICS INC
